Steris Corp.’s acquisition of Synergy Health plc., which would allow the Mentor, Ohio, provider of medical device sterilization services to invert as a British company, faces a significant setback as U.S. regulators seek to block the deal on antitrust grounds. Jeffery Cross, a member of the Litigation Practice Group and Antitrust & Trade Regulation Group, comments for a CTFN story about the timetable and steps involved in the Federal lTrade Commission challenge of the deal. The article, "Steris Acquisition of Synergy Health Uncertain After FTC Challenge," was published June 2.
To read the article, click here (subscription required).
Reprinted with permission and under license by CTFN and CTFinancialNews. No forwarding, sharing, or other republication is permitted. For additional news on significant antitrust matters and major corporate developments visit ctfinancialnnews.com. For subscription information contact [email protected].
